| Review/Discussion | Descriptive | Intervention | In the News |
Columbia University | Organizations | Research Resources |
REVIEW and DISCUSSION ARTICLES
View The Tao of Antibiotic Resistance on YouTube!
Send a CDC Health-e-Card: Personalize Healthy Antibiotics Use!
Meyer B, Cookson B. Does microbial resistance or adaptation to biocides create a hazard in infection prevention and control? J Hosp Infec 2010; 76:200-205.
Chua K, Laurent F, Coombs G, Grayson ML, Howden BP. Not community-associated methicillin resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA--its evolving antimicrobial resistance and implications for therapy. CID 2011; 52:99-114.
Curcio D. Resistant pathogen-associated skin and skin-structure infections: antibiotic options. Expert Rev Anti Infect Ther 2010;8(9):1019-36.
Rehm SJ, Tice A. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus. Clin Infect Dis 2010;51 Suppl 2:S176-82.
Cohen B, Larson EL, Stone PW, Neidell M, Glied SA. Factors associated with variation in estimates of the cost of resistant infections. Medical Care 2010;48(9):767-75.
Patel SJ, Saiman L. Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship. Clin Perinatol 2010;37:547-63.
Nathanson E, Nunn P, Uplekar M, et al. MDR tuberculosis—critical steps for prevention and control. N Engl J Med 2010;363:1050-8.
Gandhi TN, DePestel DD, Collins CD, Nagel J, Washer LL. Managing antimicrobial resistance in intensive care units. Critical Care Medicine 2010;38:S315-23.
Lin MY, Hayden MK. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: Recognition and prevention in intensive care units. Critical Care Medicine 2010;38:S335-44.
Sykes RJ. The 2009 Garrod Lecture: the evolution of antimicrobial resistance: a Darwinian perspective. Antimicrob Chemother 2010 Jun 23 [Epub ahead of print].
Rafailidis PI, Bliziotis IA, Falagas ME. Case-Control Studies Reporting on Risk Factors for Emergence of Antimicrobial Resistance: Bias Associated with the Selection of the Control Group. Microb Drug Resist 2010 Jun 7 [Epub ahead of print]
Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: system review and meta-analysis. BMJ 2010 May 18;340.
Gootz TD. The global problem of antibiotic resistance. Crit Rev Immunol 2010;30(1):79-93.
Stone PW, Glied SA, McNair PD, Matthes N, Cohen B, Landers TF, Larson EL. CMS Changes in reimbursement for HAIs: setting a research agenda. Medical Care. [Epub ahead of print.]
Huttner B, Goossens H, Verheij T, Harbarth S; on behalf of the CHAMP consortium. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infectious Diseases 2010;10(1):17-31.
Burki T. Push and pull of antibiotic development. The Lancet Infectious Diseases 2010;10:12-13.
Laxminarayan R, Malani A, Howard D, Smith D. Extending the cure: policy responses to the growing threat of antibiotic resistance. Resources for the future, 2007.
Gordon NC, Wareham DW. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents. 2010 Jan 2. [Epub ahead of print]
Bad Bugs, No Drugs As Antibiotic Discovery Stagnates...A Public Health Crisis Brews. Infectious Diseases Society of America.
Antimicrobial Resistance State Fact Sheets Map. Infectious Disease Society of America.
Mossialos E, Morel C, Edwards S, Berenson J, Gemmill-Toyama M, Brogan D. Policies and incentives for promoting innovation in antibiotic research. The London School of Economics & Political Science. 2009.
The bacterial challenge: time to react. Technical Report. European Centre for Disease Prevention and Control. 2009.
Huang H, Weintraub A, Fang H, Nord CE. Antimicrobial resistance in Clostridium difficule. Int J Antimicrob Agents 2009 Oct 12 [Epub ahead of print].
Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nature Reviews Microbiology 2009;7:629-641.
Focus on Antibiotic Stewardship. International Journal of Antimicrobial Agents; Volume 34, Supplement 3, Pages i, S1-S19 (August 2009).
Gould IM. Antibiotic resistance: the perfect storm. International Journal of Antimicrobial Agents 2009;34:S2-S5.
Wilcox MH. The tide of antimicrobial resistance and selection. International Journal of Antimicrobial Agents 2009;34:S6-S10.
Liebowitz LD. MRSA burden and interventions. International Journal of Antimicrobial Agents 2009;34:S11-S13.
García MS. Early antibiotic treatment failure. International Journal of Antimicrobial Agents 2009;34:S14-S19.
Johnsen PJ, Townsend JP, Bøhn T, et al. Factors Affecting the Reversal of Antimicrobial Drug Resistance. Lancet Infect Dis 2009;9(6):357-64.
Johnston BL, Bryce E. Hospital Infection Control Strategies for Vancomycin-resistant Enterococcus, Methicillin-Resistant Staphylococcus aureus and Clostridium difficile. CMAJ 2009;180(6):627-31.
Kirkland KB. Bacterial colonization: Can we live with it? Clinical Infectious Diseases 2009;48:1382-1384.
Low DE. Fluoroquinolones for treatment of community-acquired pneumonia and tuberculosis: putting the risk of resistance into perspective. Clinical Infectious Diseases 2009;48:1361-1363.
Powers JH. Risk perception and inappropriate antimicrobial use: yes, it can hurt. Clinical Infectious Diseases 2009;48:1350-1353.
Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st Century - A clinical super-challenge. N Engl J Med 2009;360:439-443.